Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune hemolytic anemia

S Izui1

  • 1Department of Pathology, Centre Médical Universitaire, Geneva, Switzerland.

Current Opinion in Immunology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Autoimmune hemolytic anemia (AHA) involves autoantibodies destroying red blood cells (RBCs). Identifying T-cell epitopes is crucial for understanding AHA

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.

Genes and immunity·2006
Same author

Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.

Clinical and experimental immunology·2006
Same author

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

Immunity·2002
Same author

Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis.

Pathology international·2002
Same author

Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

Springer seminars in immunopathology·2002
Same author

An experimental model of cryoglobulin-associated vasculitis in mice.

Springer seminars in immunopathology·2001
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Area of Science:

  • Immunology
  • Hematology

Background:

  • Autoimmune hemolytic anemia (AHA) is an autoimmune disorder characterized by autoantibodies targeting red blood cells (RBCs).
  • While B-cell responses in AHA are increasingly understood through studies of autoantibodies in mice, T-cell immunity remains less explored.

Purpose of the Study:

  • To highlight the significance of identifying T-cell epitopes in the context of MHC class II molecules for understanding AHA pathogenesis.
  • To emphasize the need for further research into T-cell responses in autoimmune hemolytic anemia.

Main Methods:

  • Analysis of monoclonal anti-RBC autoantibodies from autoimmune New Zealand black mice.
  • Studies involving transgenic mice expressing pathogenic IgM anti-RBC autoantibodies.

Main Results:

Related Experiment Videos

  • Research has advanced the understanding of B-cell responses in AHA.
  • Knowledge regarding T-cell immunity in AHA is still limited, indicating a gap in current understanding.

Conclusions:

  • Identifying the major T-cell epitope within MHC class II molecules is critical for elucidating the cellular and molecular mechanisms of AHA development.
  • Further investigation into T-cell involvement is essential for a comprehensive understanding of autoimmune hemolytic anemia.